Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > APP Announces Positive Results of Intra-Arterial ABI-007

June 4th, 2003

APP Announces Positive Results of Intra-Arterial ABI-007

Abstract:
At the American Society of Clinical Oncology annual meeting held in Chicago, Illinois, American Pharmaceutical Partners, Inc. said that investigators from the Insituto dei Tumori in Milan, Italy, reported on their experience in 108 patients receiving high dose ABI-007, a novel cremophor-free protein engineered nanoparticle paclitaxel, by the intra-arterial route.

Source:
APP

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

A*STAR, One BioMed launch S$9m joint lab to make diagnostic kit for infectious diseases December 3rd, 2018

New research could fine-tune the gene scissors CRISPR December 1st, 2018

It's not a shock: Better bandage promotes powerful healing November 29th, 2018

Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results November 27th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project